Our leaders drive cutting-edge research and operational success
Our leaders are both dynamic and experts in the field. They drive the CPO’s mission of “Extraordinary Research. Exceptional Care.”
They have a clear vision of a future where patients have more treatment options and reduced cancer incidence and aim to make this vision a reality by setting goals and motivating an innovative team to open cutting-edge clinical trials and maximize enrollment of diverse patient populations.
Our leaders guide the operationalization of a portfolio of more than 400 clinical trials led by more than 150 individuals.
“The scientific advances driving the era of personalized cancer medicine are tremendous, but we need to take an equally intense look at the clinical trial processes and operations that will facilitate enrollment of patients on the innovative trials that will bring these new treatments from bench to bedside.”
— Carrie Lee, MD, MPH, Clinical Protocol Office medical director
Our leaders are recognized in the field for their success
Our leaders are recognized experts in the field developing novel solutions to better operationalize clinical research including bringing these new treatments from the bench to bedside.
Medical Director Carrie Lee, MD, MPH: Appointed Chair of the Association of American Cancer Institute’s (AACI) Clinical Research Initiative (CRI) Steering Committee (2017-2019). AACI established the Clinical Research Initiative over 10 years ago to develop better methods to disseminate information across cancer centers, identify and address clinical research challenges, and measure progress. Previously Dr. Lee served on the AACI CRI Steering Committee from 2016-2017.
Carrie Lee, MD, MPH: First-authored a manuscript in the Journal of Clinical Oncology (JCO) Oncology Practice: “Clinical Trial Metrics: The Complexity of Conducting Clinical Trials in North American Cancer Centers” (PMID: 33186085). This publication was the first publicly available benchmark data set to characterize the size, cost, volume and efficiency of cancer clinical trial offices used to support the investigation of cancer prevention, early detection and treatment at cancer centers across North America.
CPO Director Theresa Cummings, RN, MS, CCRC: Currently serves on the AACI CRI Shared Investigator Platform (SIP) Task Force. The SIP is designed to facilitate interactions between investigators and multiple clinical trial sponsors, enabling study planning, start-up and conduct activities while reducing administrative burden on site staff. She previously served on the AACI CRI Steering Committee from 2016-2019.
Director of UNC Lineberger Sponsored Clinical Research J. Kaitlin Morrison, PhD: Currently serves on the External Advisory Committee for the Master of Professional Science (MPS) in Regulatory Science Degree Program at the UNC Eshelman School of Pharmacy. This program is designed to develop future leaders and innovators in pharmaceutical sciences.
Our leaders have served as external advisors to other cancer center’s clinical trial offices
Our leaders serve as invited speakers at national meetings and events
For the last six years, our leaders have been invited speakers at AACI Clinical Research Initiative and/or Cancer Center Administrators Forum including but not limited to:
- Theresa Cummings, RN, DBA, CCRC, “Capturing Clinical Research Documentation in the EMR” (2021)
- Assistant Director of Clinical Research Operations Stefanie Belanger, MHA, CCRP, “Facilitating Change” (2020)
- Carrie Lee, MD, MPH, “Completing the NCI Cancer Center Support Grant and Meeting New Expectations” (2020)
- Kaitlin Morrison, PhD, “Note to Self: Ten Lessons for Writing and Running a Trial- 5 Tips for Developing and Maintaining an IND” (2018)
AACI Roundtable Discussion: Investigator-Initiated Clinical Trials Support Programs (2021): Kaitlin Morrison, PhD, presented on “Gene Therapy – FDA and Local Regulatory Considerations.”
Center for Information and Study on Clinical Research Participation (2020): Stefanie Belanger, MHA, CCRP, presented on “What Clinical Research Means to You.”
Advarra Virtual Symposium: Gene Therapy in the Age of COVID-19 (2020): Kaitlin Morrison, PhD, presented on “Gene Therapy – FDA and Local Regulatory Considerations.”
Our leaders present their accomplishments at national meetings
For the last five years, our leaders have presented poster presentations at AACI Clinical Research Initiative with some highlights including:
- Stefanie Belanger, MHA, CCRP, and Assistant Director of Clinical Research & Network Operations Stephanie Ladd, CCRP, “Building a Clinical Career Ladder” (2019)
- Clinical Regulatory Manager Shaw Scott, JD, and J. Kaitlin Morrison, PhD, “Heat Mapping Noncompliance to Better Target the Extent of Corrective and Preventive Action Plans and Training” (2019)